NextCure, Inc.
NXTC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $22 | $32 | $39 | $166 |
| - Cash | $28 | $13 | $27 | $12 |
| + Debt | $6 | $7 | $7 | $0 |
| Enterprise Value | -$0 | $25 | $20 | $153 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$54 | -$64 | -$72 | -$67 |
| % Margin | – | – | – | – |
| Net Income | -$56 | -$63 | -$75 | -$69 |
| % Margin | – | – | – | – |
| EPS Diluted | -23.88 | -27.039 | -32.324 | -30.152 |
| % Growth | 11.7% | 16.3% | -7.2% | – |
| Operating Cash Flow | -$41 | -$53 | -$54 | -$57 |
| Capital Expenditures | -$0 | -$1 | -$2 | -$2 |
| Free Cash Flow | -$41 | -$54 | -$56 | -$60 |